Respiratory Distress in Newborn Causes Symptoms Diagnosis Treatment Neonatology Guide

By: | Category: Paediatrics | Views: 5

Respiratory Distress in the Newborn: A Comprehensive Clinical Overview
Introduction and Epidemiology
Respiratory distress is one of the most common reasons for admission to the neonatal intensive care unit (NICU), affecting approximately 7% of all newborns and up to 30% of preterm infants. It represents a spectrum of conditions ranging from transient, self-limited processes to life-threatening emergencies requiring immediate intervention. The transition from fetal to neonatal life represents the most profound physiological adaptation that humans ever undergo, and any disruption to this delicate process can manifest as respiratory distress.

The fetus exists in a fluid-filled environment where gas exchange occurs via the placenta. At birth, within seconds to minutes, the newborn must clear lung fluid, establish functional residual capacity, and initiate sustained ventilation. This transition involves complex interactions between pulmonary, cardiovascular, and neurological systems. Understanding the pathophysiology of respiratory distress requires appreciation of both normal transition and the myriad ways it can fail.

Fetal Lung Development and Preparation for Birth
To understand respiratory distress, one must first appreciate normal lung development. The human lung undergoes five distinct stages of development. The embryonic stage (3-7 weeks) sees the formation of the trachea and major bronchi from the foregut. The pseudoglandular stage (7-16 weeks) involves branching of the conducting airways. The canalicular stage (16-26 weeks) is critical as respiratory bronchioles develop and the capillary bed begins to approximate the airways. The saccular stage (26-36 weeks) involves formation of terminal saccules and the appearance of type I and II pneumocytes. Finally, the alveolar stage (36 weeks to term and beyond) sees the development of true alveoli, though alveolarization continues well into childhood.

Type II pneumocytes begin producing surfactant around 24-26 weeks gestation, but adequate quantities for stable alveolar function are typically not present until 34-36 weeks. This explains why prematurity is the single greatest risk factor for respiratory distress syndrome. Surfactant, a complex mixture of phospholipids (primarily phosphatidylcholine) and proteins (SP-A, SP-B, SP-C, SP-D), reduces alveolar surface tension, preventing collapse at end-expiration. Without adequate surfactant, alveoli become unstable, leading to progressive atelectasis, ventilation-perfusion mismatch, and hypoxemia.

During fetal life, the lungs are filled with liquid produced by the pulmonary epithelium. This liquid is essential for lung growth and development, maintaining the lungs in a distended state. Fetal breathing movements, which occur intermittently throughout gestation, are important for respiratory muscle development and lung growth. Near term, the composition of fetal lung fluid changes, and the fetus begins to reabsorb some of this fluid in preparation for birth.

The Transition at Birth: Normal Physiology
At delivery, several coordinated events must occur for successful transition. The first breath requires overcoming tremendous forces: the surface tension of residual lung fluid, the viscosity of fluid in the airways, and the elastic recoil of the chest wall and lungs. Newborns generate negative intrathoracic pressures of 30-60 cm H2O during the first breaths, far exceeding the pressures generated during normal breathing later in life.

The clearance of fetal lung fluid is a active, hormonally-mediated process. Catecholamine surges during labor stimulate alveolar epithelial sodium channels (ENaC), promoting sodium reabsorption from the alveolar lumen. Water follows passively through aquaporin channels, moving from the airspaces into the interstitium. From there, it is removed by pulmonary lymphatics and the pulmonary circulation. This process explains why infants delivered by cesarean section without labor are at higher risk for transient tachypnea—they miss the catecholamine surge and thoracic compression that facilitate fluid clearance.

Simultaneously, the pulmonary vascular resistance must fall dramatically. In utero, pulmonary vascular resistance is high due to low oxygen tension, relative acidosis, and mechanical factors. Only 8-10% of fetal cardiac output perfuses the lungs. With the first breaths, alveolar oxygen tension rises, carbon dioxide falls, and pH normalizes. These changes trigger pulmonary vasodilation, increasing pulmonary blood flow 8-10 fold. This increased return to the left atrium elevates left atrial pressure above right atrial pressure, functionally closing the foramen ovale. Rising oxygen tension also constricts the ductus arteriosus, though anatomical closure takes 24-48 hours.

Clinical Presentation: Recognizing Respiratory Distress
The signs of respiratory distress in newborns are often obvious but require systematic assessment. Tachypnea is typically the earliest sign, defined as a respiratory rate persistently above 60 breaths per minute. However, normal newborn respiratory rate can vary from 30-60 breaths per minute, especially during active sleep, so sustained elevation is more concerning than intermittent tachypnea.

Retractions occur when the compliant newborn chest wall is pulled inward by negative intrathoracic pressure generated against obstructed or stiff lungs. The location of retractions provides clues to the underlying pathology. Subcostal and intercostal retractions suggest lower airway or parenchymal disease, while suprasternal and supraclavicular retractions point to upper airway obstruction. In severe distress, one may see see-saw breathing, where the chest collapses as the abdomen rises with diaphragmatic contraction, indicating diaphragmatic fatigue.

Grunting is a distinctive sound produced when the newborn exhales against a partially closed glottis. This auto-PEEP (positive end-expiratory pressure) mechanism is an attempt to maintain alveolar recruitment and prevent collapse. While grunting is often associated with surfactant deficiency, it can occur in any condition where the infant perceives benefit from maintaining positive airway pressure. The disappearance of grunting in a distressed infant may indicate fatigue rather than improvement.

Nasal flaring is another compensatory mechanism. By flaring the nares, the infant reduces nasal resistance, decreasing the work of breathing. Cyanosis, particularly central cyanosis involving the trunk and mucous membranes, indicates significant hypoxemia. Peripheral cyanosis (acrocyanosis) of the hands and feet is common in the first 24-48 hours due to immature peripheral circulation and is not concerning in isolation.

Apnea, the cessation of breathing for more than 20 seconds or shorter duration if associated with bradycardia or desaturation, represents a failure of respiratory drive. Apnea can be central (lack of respiratory effort), obstructive (effort without airflow), or mixed. Premature infants are particularly susceptible to apnea due to immature respiratory control centers.

Specific Causes of Respiratory Distress
Respiratory Distress Syndrome (Hyaline Membrane Disease)
Respiratory distress syndrome (RDS) remains the most common cause of respiratory distress in preterm infants, though it can occasionally affect term infants, particularly those of diabetic mothers. The pathophysiology is surfactant deficiency leading to alveolar collapse at end-expiration. Without surfactant, surface tension forces become overwhelming, causing progressive atelectasis. This creates a vicious cycle: atelectasis causes hypoxemia, which worsens pulmonary vasoconstriction, reducing perfusion to already poorly ventilated areas, exacerbating ventilation-perfusion mismatch.

The classic presentation includes tachypnea, grunting, nasal flaring, and retractions beginning immediately or within hours of birth. Chest radiography reveals diffuse, fine granular opacities (ground-glass appearance) with air bronchograms extending to the periphery. The granular pattern represents collapsed alveoli interspersed with overdistended terminal airways, while air bronchograms occur because air-filled bronchi stand out against the opaque, atelectatic lung parenchyma.

Without treatment, RDS progresses over 48-72 hours as surfactant-consuming processes (atelectasis, inflammation, protein leak) overwhelm the already deficient surfactant pool. The natural history, prior to modern therapy, was progressive respiratory failure, often with death around day 3-4. Today, antenatal corticosteroids, exogenous surfactant, and sophisticated respiratory support have dramatically improved outcomes.

Transient Tachypnea of the Newborn
Transient tachypnea of the newborn (TTN) results from delayed clearance of fetal lung fluid. It occurs most commonly in term or late preterm infants delivered by cesarean section without labor, but can also occur after precipitous delivery, in infants of asthmatic mothers, or with excessive maternal sedation. The retained fluid in the alveoli and interstitium decreases lung compliance, increases work of breathing, and stimulates rapid, shallow respirations.

Infants with TTN present with tachypnea often exceeding 80-100 breaths per minute, mild retractions, and occasional grunting. Unlike RDS, the onset may be within the first few hours rather than immediately, and the course is self-limited, typically resolving within 24-48 hours. Chest radiography shows prominent central vascular markings, fluid in the interlobar fissures, and sometimes mild cardiomegaly. The lung fields are typically clear peripherally, unlike the diffuse granular pattern of RDS.

The pathophysiology involves failure of the active sodium transport mechanism. Epithelial sodium channels (ENaC) must be activated by catecholamines, cortisol, and other hormones. Without the catecholamine surge of labor, this activation is delayed. Fluid remains in the interstitium, increasing lymphatic load and reducing compliance. As the infant breathes rapidly, she generates high negative pressures that actually promote further fluid accumulation in the interstitium by increasing venous return to the chest.

Meconium Aspiration Syndrome
Meconium aspiration syndrome (MAS) occurs when a stressed fetus passes meconium in utero and then gasps, aspirating the meconium-stained fluid into the lungs. The pathophysiology is complex and involves three mechanisms: airway obstruction, surfactant inactivation, and chemical pneumonitis.

Meconium is a thick, tenacious material consisting of gastrointestinal secretions, bile, pancreatic juices, and desquamated cells. When aspirated, it causes partial or complete airway obstruction. Partial obstruction creates a ball-valve effect where air enters during inspiration but cannot exit during expiration, leading to air trapping, hyperinflation, and increased risk of pneumothorax. Complete obstruction causes atelectasis distal to the obstruction. The result is uneven ventilation with areas of overdistension adjacent to collapsed areas.

Meconium also directly inactivates surfactant. The free fatty acids, bile salts, and other components disrupt the phospholipid monolayer, increasing surface tension. This contributes to atelectasis and worsens respiratory mechanics. Additionally, meconium triggers an intense inflammatory response, with release of cytokines, recruitment of neutrophils, and chemical pneumonitis. This inflammation can progress to pneumonitis and, in severe cases, persistent pulmonary hypertension.

The classic infant with MAS is post-term or term, with meconium-stained amniotic fluid. At birth, the infant may be depressed with low Apgar scores. The chest is often barrel-shaped from air trapping. Breath sounds are coarse with crackles and rhonchi. Chest radiography shows coarse, irregular patchy opacities, hyperinflation with flattened diaphragms, and sometimes pneumothorax or pneumomediastinum.

Persistent Pulmonary Hypertension of the Newborn
Persistent pulmonary hypertension of the newborn (PPHN) represents failure of the normal postnatal drop in pulmonary vascular resistance. The pulmonary circulation remains in a high-resistance fetal state, with right-to-left shunting across the ductus arteriosus and foramen ovale, causing severe hypoxemia. PPHN can be primary (idiopathic) but more commonly complicates other conditions like meconium aspiration, sepsis, pneumonia, or asphyxia.

The pathophysiology involves maladaptation of the pulmonary vasculature. Three patterns exist: (1) vasoconstriction from acute stressors (hypoxia, acidosis, hypothermia), which is potentially reversible; (2) vascular remodeling from chronic in utero stress (chronic hypoxia, ductal closure in utero), leading to medial hypertrophy and fixed pulmonary hypertension; and (3) hypoplastic vasculature as in congenital diaphragmatic hernia.

Infants with PPHN present with severe cyanosis and respiratory distress out of proportion to lung parenchymal disease. A characteristic finding is differential cyanosis, with higher oxygen saturation in the right upper extremity (pre-ductal) than in the lower extremities (post-ductal), though this requires a patent ductus with right-to-left shunting. The response to 100% oxygen is typically poor, as the problem is not diffusion limitation but shunting. Echocardiography is diagnostic, showing elevated right ventricular pressure, right-to-left shunting, and excluding structural heart disease.

Pneumonia and Sepsis
Neonatal pneumonia can present with respiratory distress indistinguishable from other causes. Group B Streptococcus (GBS) remains the most common bacterial pathogen, though E. coli, Listeria monocytogenes, and other organisms are important. Pneumonia may be acquired in utero (ascending infection), during delivery (exposure to colonized birth canal), or postnatally.

The pathophysiology involves inflammation, exudate, and edema in the alveoli and interstitium. This decreases compliance, increases work of breathing, and causes ventilation-perfusion mismatch. In GBS pneumonia, the organism can cause a particularly severe illness that mimics RDS clinically and radiographically, with diffuse granular opacities and air bronchograms. The distinction is critical, as RDS requires surfactant while GBS pneumonia requires antibiotics.

Sepsis without pneumonia can also cause respiratory distress through multiple mechanisms: metabolic acidosis stimulating compensatory tachypnea, inflammatory mediators increasing capillary permeability and pulmonary edema, or sepsis-induced myocardial dysfunction leading to pulmonary edema from heart failure.

Air Leak Syndromes
Pneumothorax, pneumomediastinum, and pulmonary interstitial emphysema occur when air escapes from the normal airways into spaces where it does not belong. These can be spontaneous (particularly in term infants with vigorous first breaths) or secondary to underlying lung disease and positive pressure ventilation.

The pathophysiology involves alveolar overdistension and rupture. Air enters the interstitium (pulmonary interstitial emphysema), tracks along bronchovascular sheaths, and may rupture into the pleural space (pneumothorax), mediastinum (pneumomediastinum), or pericardium (pneumopericardium). Tension pneumothorax is life-threatening because intrapleural pressure exceeds venous pressure, impairing venous return and cardiac output.

Sudden deterioration in a ventilated infant should always prompt consideration of pneumothorax. Physical findings include asymmetric breath sounds, hyperresonance to percussion, shift of the cardiac impulse, and sometimes subcutaneous emphysema. Transillumination of the chest may reveal hyperlucency on the affected side, but chest radiography is diagnostic.

Congenital Anomalies
Numerous congenital anomalies can present with respiratory distress. Congenital diaphragmatic hernia (CDH) occurs when the diaphragm fails to close, allowing abdominal viscera to herniate into the chest. This compresses the developing lung, causing pulmonary hypoplasia and abnormal pulmonary vascular development. The degree of hypoplasia determines prognosis. CDH presents with respiratory distress, scaphoid abdomen, and bowel sounds in the chest. Chest radiography shows bowel loops in the hemithorax with mediastinal shift.

Choanal atresia, the failure of the posterior nasal airways to canalize, causes respiratory distress because newborns are obligate nasal breathers. Infants present with cyclical cyanosis that improves with crying (when they breathe through the mouth). Diagnosis is made by failure to pass a nasogastric tube through the nares.

Tracheoesophageal fistula and esophageal atresia present with excessive oral secretions, choking with feeds, and respiratory distress. The classic finding is inability to pass a nasogastric tube, with the tube coiling in the proximal esophageal pouch seen on radiography. Aspiration of oral secretions or refluxed gastric contents through the fistula causes chemical pneumonitis and respiratory distress.

Other anomalies including cystic adenomatoid malformations, pulmonary sequestration, congenital lobar emphysema, and vascular rings can all present with varying degrees of respiratory distress depending on their size and location.

Diagnostic Approach
The evaluation of an infant with respiratory distress begins with history and physical examination, then proceeds to appropriate diagnostic studies. Important historical elements include gestational age, mode of delivery, presence of labor, maternal conditions (diabetes, hypertension, infection), prolonged rupture of membranes, meconium-stained fluid, and Apgar scores.

Physical examination should assess the severity of distress, the pattern of retractions, breath sounds (symmetry, quality, adventitious sounds), and cardiac examination. The infant should be evaluated for dysmorphic features that might suggest a syndrome. Vital signs including pre-ductal and post-ductal oxygen saturations help assess for PPHN.

Chest radiography is the most important initial diagnostic study. The pattern of findings often suggests the diagnosis: granular opacities with air bronchograms suggest RDS; hyperinflation with coarse patchy opacities suggests MAS; prominent vascular markings and fluid suggest TTN; hyperlucent hemithorax suggests pneumothorax; bowel in the chest suggests CDH.

Blood gas analysis assesses the severity of hypoxemia and acidosis and guides respiratory support. A complete blood count and blood culture are indicated when infection is suspected. Echocardiography is essential when PPHN or congenital heart disease is considered.

Principles of Management
Management of neonatal respiratory distress follows several principles: support oxygenation and ventilation while minimizing lung injury, treat the underlying cause, and prevent complications.

Respiratory Support
The approach to respiratory support depends on severity. Mild distress may require only supplemental oxygen by hood or nasal cannula. Moderate distress often benefits from continuous positive airway pressure (CPAP), which recruits and stabilizes alveoli, improving oxygenation and reducing work of breathing. CPAP is particularly effective in RDS and TTN.

Severe distress requires mechanical ventilation. Modern neonatal ventilators offer multiple modes, including conventional ventilation and high-frequency ventilation. The goal is to achieve adequate gas exchange while minimizing volutrauma, barotrauma, and oxygen toxicity. Permissive hypercapnia (allowing PaCO2 to rise modestly) and careful oxygen targeting (SpO2 90-95%) are strategies to reduce lung injury.

Surfactant replacement therapy has revolutionized the management of RDS. Natural surfactant preparations (derived from animal lungs) contain phospholipids and surfactant proteins, while synthetic preparations contain only phospholipids. Administration via endotracheal tube rapidly improves oxygenation and reduces mortality. Early selective surfactant administration (to infants requiring intubation) is more effective than later rescue therapy.

Specific Therapies
For PPHN, therapies aimed at reducing pulmonary vascular resistance include inhaled nitric oxide, a selective pulmonary vasodilator. Inhaled nitric oxide improves oxygenation and reduces the need for ECMO in infants with hypoxemic respiratory failure and PPHN. Other pulmonary vasodilators including sildenafil and prostacyclin analogs may be used in refractory cases.

Antibiotics are administered when infection is suspected, typically ampicillin and gentamicin or cefotaxime for GBS coverage. Therapy is adjusted based on culture results and discontinued if cultures remain negative at 48 hours.

For meconium aspiration, gentle ventilation to avoid overdistension, surfactant for surfactant inactivation, and treatment of PPHN are mainstays. Historically, intubation and suctioning of meconium from the trachea was recommended for all non-vigorous infants, but current evidence suggests this may not improve outcomes and may cause harm.

Extracorporeal Membrane Oxygenation (ECMO)
ECMO provides cardiorespiratory support for infants with reversible respiratory failure unresponsive to maximal medical therapy. Venovenous ECMO supports the lungs while venoarterial ECMO supports both heart and lungs. ECMO is reserved for the most severe cases with predicted mortality exceeding 80%, typically those with oxygenation index >40. Complications include bleeding, thrombosis, and neurological injury.

Complications and Outcomes
Respiratory distress and its treatment can lead to numerous complications. Air leak syndromes (pneumothorax, pneumomediastinum) occur in up to 10% of ventilated infants. Chronic lung disease (bronchopulmonary dysplasia) develops in premature infants requiring prolonged respiratory support, characterized by persistent oxygen requirement at 36 weeks postmenstrual age. Intraventricular hemorrhage and periventricular leukomalacia are associated with respiratory instability and hypoxia. Retinopathy of prematurity results from oxygen toxicity in premature infants.

Long-term outcomes depend on the underlying condition, severity, and complications. Most infants with TTN recover completely. Infants with RDS who receive surfactant and gentle ventilation have excellent outcomes, though those with extreme prematurity remain at risk for neurodevelopmental impairment. MAS and PPHN carry risks of neurological injury from hypoxia. Infants with CDH have variable outcomes depending on the degree of pulmonary hypoplasia.

Prevention
Antenatal corticosteroids administered to mothers at risk for preterm delivery dramatically reduce the incidence and severity of RDS. Betamethasone or dexamethasone given at least 24 hours before delivery accelerate surfactant production and lung maturation.

Prevention of preterm birth remains the ultimate goal but is often elusive. Optimal management of maternal diabetes, prevention of chorioamnionitis, and appropriate timing of cesarean section (avoiding elective delivery before 39 weeks) reduce the risk of respiratory distress. GBS prophylaxis for colonized mothers prevents early-onset GBS sepsis and pneumonia.

Conclusion
Respiratory distress in the newborn represents a final common pathway for numerous conditions affecting the transition from fetal to neonatal life. Understanding the underlying pathophysiology—whether surfactant deficiency, delayed fluid clearance, meconium aspiration, persistent pulmonary hypertension, infection, or congenital anomalies—guides appropriate management. With modern respiratory support, surfactant therapy, and advanced interventions like inhaled nitric oxide and ECMO, most infants survive, though long-term neurodevelopmental follow-up remains important for those with severe illness. The key to optimal outcomes remains early recognition, accurate diagnosis, and timely intervention tailored to the specific pathophysiology.